Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.41 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.40 |
| ▸ | RELA | Q04206 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | GBA1 | P04062 | 1/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11976565 | 0.86 | MEN1 (0.47) | HPGDSNPC1RAB9AADORA3ADORA1 | |
| SCHEMBL12628226 | 0.86 | L3MBTL1 (0.57) | HPGDSNPC1RAB9AADORA3ADORA1 | |
| SCHEMBL2757249 | 0.82 | HPGDS (0.48) | HPGDSNPC1RAB9APDGFRBPDGFRA | |
| SCHEMBL17051529 | 0.82 | HPGDS (0.48) | HPGDSNPC1RAB9APDGFRBPDGFRA | |
| SCHEMBL6111135 | 0.82 | L3MBTL1 (0.52) | NPC1RAB9AADORA3ADORA1MEN1 | |
| SCHEMBL11810896 | 0.82 | L3MBTL1 (0.52) | NPC1RAB9AADORA3ADORA1MEN1 | |
| SCHEMBL11976547 | 0.81 | L3MBTL1 (0.45) | NPC1RAB9AADORA3ADORA1PDGFRB | |
| SCHEMBL28791301 | 0.81 | HPGDS (0.44) | HPGDSNPC1RAB9AADORA3PKM | |
| SCHEMBL11976553 | 0.81 | L3MBTL1 (0.45) | NPC1RAB9AADORA3ADORA1PDGFRB | |
| SCHEMBL16189444 | 0.80 | L3MBTL1 (0.55) | HPGDSNPC1RAB9AADORA3ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9048442-B2 | Composition containing a metal complex and organic compound, and light-emitting element using said compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-06-02 | — | — | US | disclosed |
| US-9048442-B2 | Composition containing a metal complex and organic compound, and light-emitting element using said compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-06-02 | — | — | US | disclosed |
| US-20120205585-A1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-16 | — | — | US | disclosed |
| US-20110114890-A1 | COMPOSITION CONTAINING A METAL COMPLEX AND ORGANIC COMPOUND, AND LIGHT-EMITTING ELEMENT USING SAID COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-19 | — | — | US | disclosed |
| US-20110114890-A1 | COMPOSITION CONTAINING A METAL COMPLEX AND ORGANIC COMPOUND, AND LIGHT-EMITTING ELEMENT USING SAID COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120205585-A1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME | HDAC10, EMG1, PRMT1 | HPGDS 4732/4885NPC1 1597/4885RAB9A 470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.